BNP Paribas Financial Markets Increases Stake in Tenet Healthcare Corporation $THC

BNP Paribas Financial Markets grew its position in Tenet Healthcare Corporation (NYSE:THC) by 24.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 228,144 shares of the company’s stock after acquiring an additional 45,020 shares during the period. BNP Paribas Financial Markets’ holdings in Tenet Healthcare were worth $45,337,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Norges Bank bought a new position in shares of Tenet Healthcare in the fourth quarter worth approximately $248,494,000. Eurizon Capital SGR S.p.A. bought a new position in shares of Tenet Healthcare in the fourth quarter worth approximately $390,000. Hillsdale Investment Management Inc. boosted its position in shares of Tenet Healthcare by 20.6% in the fourth quarter. Hillsdale Investment Management Inc. now owns 27,490 shares of the company’s stock worth $5,463,000 after purchasing an additional 4,690 shares during the period. Fiducient Advisors LLC bought a new position in shares of Tenet Healthcare during the fourth quarter worth $405,000. Finally, Rothschild Investment LLC boosted its position in shares of Tenet Healthcare by 11.0% during the fourth quarter. Rothschild Investment LLC now owns 1,784 shares of the company’s stock worth $355,000 after acquiring an additional 177 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Thomas W. Arnst sold 8,000 shares of the stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total value of $1,910,800.00. Following the sale, the executive vice president owned 12 shares of the company’s stock, valued at approximately $2,866.20. This represents a 99.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 23,138 shares of company stock worth $4,976,589. Insiders own 0.97% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on THC shares. Mizuho upped their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Royal Bank Of Canada dropped their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Barclays dropped their target price on shares of Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Finally, Leerink Partners upped their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research report on Friday, February 20th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $164.28 on Wednesday. The company has a market cap of $14.15 billion, a price-to-earnings ratio of 8.54, a PEG ratio of 1.12 and a beta of 1.28. The firm’s fifty day moving average is $189.23 and its 200 day moving average is $201.72. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts forecast that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.